- BCTXP is administered by the Board of Pharmacy Specialties (BPS) via Pearson VUE testing centers.
- The exam has 150 questions (125 scored) over 3 hours 45 minutes; passing requires a scaled score of 500.
- Therapeutics and Patient Management makes up 63% of the exam - the single largest content area.
- Initial exam fee is $600; retakes are $300, with a 90-day wait required between attempts.
What Is BCTXP?
BCTXP stands for Board-Certified Transplant Pharmacist, a specialty credential granted by the Board of Pharmacy Specialties (BPS) to licensed pharmacists who demonstrate advanced knowledge in the care of solid organ transplant recipients. This is not a general pharmacy license - it is a post-licensure specialty certification that signals a pharmacist has the clinical depth to manage immunosuppression, drug interactions, and complex comorbidities across the transplant continuum, from pre-transplant workup through long-term outpatient management.
Anyone researching this credential should be careful about the acronym: other unrelated certifications also use "BCTXP" in different fields. On this site, BCTXP always refers exclusively to the Board-Certified Transplant Pharmacist credential defined by BPS. If you want a broader orientation before diving into the mechanics below, our companion piece on BCTXP Certification covers the credential's purpose and career context in more depth.
Who Administers BCTXP
The Board of Pharmacy Specialties is the certifying organization for BCTXP, and the exam itself is delivered through Pearson VUE testing centers. BPS sets the eligibility requirements, examination content outline, scoring methodology, and recertification policies. Because BPS periodically updates its specifications, candidates should always confirm they are studying against the current outline - the version linked from the BPS index is effective for 2025 administrations onward, with detailed specifications dated January 2024.
If you're comparing BCTXP terminology across sources, related explainer pages like BCTXP Meaning, What Does BCTXP Stand For?, and What Is A BCTXP? all point back to this same BPS-administered credential.
Exam Format and Question Style
The BCTXP exam is a closed-book, computer-based test consisting of 150 total questions: 125 scored items and 25 unscored pretest items used by BPS to evaluate future exam content. Candidates are given 3 hours and 45 minutes total, which includes time for the introduction and tutorial, not just the questions themselves.
Most items are single-answer multiple-choice questions, but BPS also incorporates multiple-response items and image-supported questions (such as lab value tables or medication regimens) into the mix. Navigation is forward-only - once you submit an answer, you cannot return to change it, and you cannot skip ahead and come back later. This format rewards decisive, methodical test-taking rather than a "flag and revisit" strategy common on other licensure exams.
- An on-screen scientific calculator is provided for dosing and pharmacokinetic calculations.
- One proctor-approved 10-minute break is allowed, but it counts against your total exam time.
- Remote testing exists as an exception requiring advance BPS approval, and is currently limited to eligible candidates in the United States, Australia, and Canada.
Passing requires a scaled score of 500 on a 200-800 scale. For a deeper breakdown of how that scaled score is calculated and what it means relative to raw questions answered correctly, see BCTXP Passing Score 2026: Exactly What You Need to Pass.
Key Takeaway
Because navigation is forward-only, practice answering under exam-like conditions where you cannot revisit questions - this changes your pacing strategy compared to review-and-revise exams.
The Three BCTXP Domains
The BCTXP exam content outline is organized into three domains, and their weighting is not even - one domain dominates the exam by a wide margin.
Domain 1: Solid Organ Transplantation (19%)
Covers the foundational science and clinical context of transplantation - organ allocation, immunology basics, surgical and perioperative considerations, and the pathophysiology that underlies transplant pharmacotherapy.
- Understand immunologic principles behind rejection and tolerance
- Know perioperative and organ-specific considerations across kidney, liver, heart, lung, and pancreas transplant
Domain 2: Therapeutics and Patient Management (63%)
By far the largest domain, this area is further broken into three components: Treatment Planning (19% of the total exam), Therapeutic Implementation (23%), and Treatment Outcomes and Monitoring (21%). Together these test a candidate's ability to design, execute, and monitor immunosuppressive and supportive drug therapy in transplant recipients.
- Immunosuppressant selection, dosing, and therapeutic drug monitoring
- Infection prophylaxis, drug interactions, and adverse effect management
- Longitudinal monitoring for rejection, toxicity, and comorbid disease progression
Domain 3: Professional Practice (18%)
Addresses the pharmacist's broader professional role - patient education, interprofessional collaboration, quality improvement, and regulatory or ethical considerations specific to transplant practice settings.
- Medication adherence strategies and patient counseling for transplant recipients
- Collaborative practice within multidisciplinary transplant teams
Given that Domain 2 alone accounts for nearly two-thirds of the exam, allocating study time proportionally to these weights is one of the highest-leverage decisions a candidate can make. For a complete walkthrough of every subtopic within each domain, see BCTXP Exam Domains 2026: Complete Guide to All 3 Content Areas.
| Domain | Weight | Focus |
|---|---|---|
| Solid Organ Transplantation | 19% | Foundational science, immunology, perioperative care |
| Therapeutics and Patient Management | 63% | Immunosuppression, monitoring, treatment planning |
| Professional Practice | 18% | Education, collaboration, regulatory practice |
Eligibility Pathways
Not every licensed pharmacist can sit for BCTXP immediately. BPS requires candidates to hold an ACPE-accredited pharmacy degree (or a qualifying international equivalent) and active pharmacist licensure or registration. Beyond that, candidates must complete one of three qualifying pathways within the preceding seven years:
- Four years of postlicensure transplant practice, with at least 50% of time spent on activities within the examination outline
- An eligible PGY1 residency plus two years of qualifying transplant practice
- An eligible PGY2 residency specifically in solid-organ-transplantation pharmacy
Candidates pursuing a practice-based pathway need employer attestation confirming their time and duties align with the outline. Because these pathways involve documentation lead time, it's worth mapping your eligibility well before your target testing window. A full breakdown of documentation requirements and how each pathway is verified is available in BCTXP Requirements 2026: Eligibility, Prerequisites & How to Qualify.
Fees, Retakes, and Scheduling
The initial BCTXP examination fee is $600 USD. Candidates who need to retake the exam and remain eligible pay a reduced $300 retake fee. BPS uses continuous testing with a 90-day window authorized to test once you're approved, giving some flexibility in scheduling around your own study timeline.
The current retake policy allows up to three total attempts. Between attempts, there is a mandatory 90-day waiting period, after which candidates have another 90 days to schedule and complete their next attempt. If a candidate fails a third time, BPS requires a 12-month wait before a brand-new application can be submitted, along with paying the full $600 fee again - effectively resetting the clock.
For exact testing windows, application deadlines, and how continuous testing periods are structured throughout the year, refer to BCTXP Exam Dates 2026: Testing Windows, Deadlines & Scheduling.
Who Hires BCTXP-Certified Pharmacists
BCTXP is a niche but meaningful credential within clinical pharmacy. It's most relevant to pharmacists working in or targeting roles at transplant centers, academic medical centers with active organ transplant programs, and specialty/outpatient clinics that manage transplant recipients long-term. Typical responsibilities in these roles include managing immunosuppressive regimens, coordinating with transplant surgeons and nephrologists/hepatologists/cardiologists, running anticoagulation or therapeutic drug monitoring clinics for transplant patients, and leading medication reconciliation and adherence counseling for this high-risk population.
Because transplant pharmacy is a small subspecialty, the credential functions less as a broad market signal and more as a targeted validation for a specific career track. If you're evaluating whether pursuing BCTXP aligns with your career goals and compensation expectations, BCTXP Salary Guide 2026: Complete Earnings Analysis and Is the BCTXP Certification Worth It? Complete ROI Analysis 2026 both dig into that decision in more detail. You can also browse current openings and how the credential is referenced in job postings via BCTXP Jobs.
Maintaining Certification
BCTXP certification is valid for seven years. For cycles beginning January 2024 onward, BPS offers two renewal routes:
- Renewal by examination plus 20 CPD/CPE units
- Renewal by professional development: 100 total units, including at least 80 BPS-approved assessed CPE units and up to 20 self-reported CPD units (assessed CPE may substitute for CPD units)
Both routes require submitting an annual reflection and plan, along with completing at least two qualifying units every year rather than saving all activity for the end of the cycle. On the cost side, annual maintenance runs $125 in years one through six, with a larger $400 recertification fee due in year seven. Planning for this ongoing cost is part of the total investment picture, covered alongside the initial exam fee in the certification cost breakdown linked above.
How to Approach Preparation
Given that Therapeutics and Patient Management represents 63% of the exam - more than three times the weight of either other domain - an efficient study sequence front-loads time on immunosuppressant pharmacology, drug interaction management, and monitoring parameters before circling back to foundational transplant science and professional practice topics.
Therapeutics and Patient Management
- Immunosuppressant selection, dosing, and therapeutic drug monitoring across organ types
- Treatment Implementation: infection prophylaxis and adverse effect protocols
Solid Organ Transplantation
- Immunology fundamentals, rejection mechanisms, organ-specific perioperative care
Professional Practice + Full Review
- Patient counseling, interprofessional collaboration, regulatory topics
- Timed practice sets replicating forward-only navigation
Because the exam does not allow reviewing or changing prior answers, practicing under that same constraint matters more for BCTXP than for many other certification exams. Using timed, forward-only practice questions builds the pacing instinct you'll need on test day. A more detailed week-by-week plan, including how to weight review sessions against the 63/19/18 domain split, is available in BCTXP Study Guide 2026: How to Pass on Your First Attempt. If you want a condensed reference for last-minute review, BCTXP Cheat Sheet 2026: One-Page Review of Must-Know Facts compiles key facts in one place.
You can build that timed practice habit directly using our BCTXP practice test platform, which mirrors the single-answer and multiple-response question styles you'll encounter on exam day.
Gauging the Exam's Difficulty
Official 2025 results show an overall pass rate of 48.8% (20 passes among 41 attempts), with first-time candidates passing at 46.4% (13 passes among 28 attempts). These numbers reflect a genuinely demanding exam rather than a formality, and they underscore why proportional domain preparation and realistic timed practice matter. For a fuller statistical breakdown and what these figures suggest about exam difficulty, see BCTXP Pass Rate 2026: What the Data Shows and How Hard Is the BCTXP Exam? Complete Difficulty Guide 2026.
Key Takeaway
With roughly half of all candidates passing, BCTXP preparation should be treated as a serious, structured commitment rather than a light review before test day.
Ready to put this outline into practice? Start working through domain-weighted questions on our practice test platform to see where your knowledge gaps sit before scheduling your exam date.
Frequently Asked Questions
BCTXP stands for Board-Certified Transplant Pharmacist, a specialty certification administered by the Board of Pharmacy Specialties for pharmacists specializing in solid organ transplant care. See What Does BCTXP Mean? for more on the terminology.
The exam includes 150 total questions - 125 scored and 25 unscored pretest items - administered over 3 hours and 45 minutes, including the tutorial.
The initial examination fee is $600 USD. Eligible retakes cost $300, and a third failed attempt requires a 12-month wait plus a new $600 application.
Therapeutics and Patient Management, which accounts for 63% of the exam, deserves the largest share of study time compared to Solid Organ Transplantation (19%) and Professional Practice (18%).
Certification lasts seven years and can be renewed either by retaking the exam plus completing 20 CPD/CPE units, or by accumulating 100 professional-development units with at least 80 assessed CPE units.